The solution detects brain lesions through automated labeling and visualization. It generates precise information on lesion changes and brain structure volumes related to Multiple Sclerosis (MS).
It counts new, increasing, diminishing, and stable lesions.

Detects breast cancer-related abnormalities in mammograms, with better precision in dense and fatty breasts. Its AI score functions as an additional report, decreasing radiologists’ reading volume and supporting their conclusions.

It detects all forms of fractures with X-rays. It plans tests in priority order. It has been clinically tested with excellent results, including avoiding 67% false negatives and saving 27% time. It is now used in 550 healthcare centers in 25 countries on four continents.